Login
$RDHL
$0.45 +$0.03 (7.74%) Close

Ownership

13F as of Q2 2026 · 50.92B shares outstanding

Who owns RDHL?

By type of holder
Institutions 0.0% Insiders 0.0% Everyone else 100.0%
Concentration Top 10 holders own 0.0%
Yorkville Advisors Global, LP 0.0% · Gagnon Securities LLC 0.0%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
14
-2 vs last qtr
Net shares bought
−202.8K
by institutions in Q2 2026
New / sold out
2 / 4
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Citadel Advisors LLC +44.6K
  • Lido Advisors, LLC NEW +11.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Yorkville Advisors Global, LP −228.7K
  • XTX Topco Ltd SOLD OUT −15.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Redhill Biopharma Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Redhill Biopharma Ltd.

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years6% 1–3 years2% Under 1 year92%
Quarterly turnover
32.9%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting RDHL on Form 13F
YA
Yorkville Advisors Global, LP
Shares
122.1K
% of company
0.00%
Change vs last qtr
−228.7K (−65.2%)
Held since
Q4 '25
GS
Gagnon Securities LLC
Shares
88.4K
% of company
0.00%
Change vs last qtr
Unchanged
Held since
Q3 '25

16 more super investors behind a free account

See every manager holding Redhill Biopharma Ltd, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting RDHL on Form N-PORT; together they hold 0.0% of the company
FN
Fidelity Concord Street Trust
Position value
$349
% of company
0.00%
% of the fund
0.00%
As of
August 31, 2024

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support